CSPC Innovation Pharmaceutical News

New Novus: Announcement on the holding subsidiary SYS6005 antibody drug conjugate obtaining approval notice for drug clinical trials

Dec 20 15:54

New Novus: Announcement on the holding subsidiary SYS6043 antibody drug conjugate obtaining approval notice for drug clinical trials

Dec 20 15:54

New Novus: Announcement on amendments to the “Articles of Association”

Dec 20 00:00

New Novus: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025

Dec 20 00:00

New Novus: Board of Directors Rules of Procedure

Dec 20 00:00

New Novus: Announcement on the completion of the registration of the change in registered capital and the issuance of a business license

Dec 5 16:46

New Novus: Announcement on the holding subsidiary obtaining US FDA fast-track qualification for externally authorized drugs

Dec 4 16:00

New Novus: Announcement on the signing of a tripartite supervisory agreement on capital raising

Dec 3 15:56

New Novus: Announcement on acceptance of the holding subsidiary\'s application for the marketing of usinumab injections

Nov 26 16:22

New Novus: Announcement on the holding subsidiary obtaining a notice of approval for drug clinical trials

Nov 12 16:22

New Novus: Legal Opinion of Beijing Junzejun Law Firm on Witnessing the 2024 Third Extraordinary General Meeting of Shareholders of Shiyao Innovative Pharmaceutical Co., Ltd.

Oct 31 18:52

New Novus: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders

Oct 31 18:52

New Novus: An indicative announcement on the disclosure of the report for the third quarter of 2024

Oct 24 00:00

New Novus: Announcement of CSPC Pharmaceutical Innovation Pharmaceutical Co., Ltd. on the acceptance of financial support and related transactions by its holding subsidiary

Oct 16 00:00

New Novus: Board Statement on the Development and Implementation of the Insider Information Insider Registration System

Oct 16 00:00

New Novus: Commitments issued by independent financial advisors based on full due diligence and core

Oct 16 00:00

New Novus: 1. General Risk Warning Notice on Issuing Shares and Paying Cash to Purchase Assets and Raising Supporting Funds and Related Transactions

Oct 16 00:00

New Novus: Announcement of CSPC Pharmaceutical Innovation Pharmaceutical Co., Ltd. on changing some fund-raising investment projects and using raised funds to pay capital increases and provide loans to subsidiaries to implement fund-raising projects

Oct 16 00:00

New Novus: The Board\'s statement on the absence of paid employment of other third parties or individuals

Oct 16 00:00

New Novus: Board statement on the independence of the evaluation agency, the rationality of evaluation assumptions, the relevance of the evaluation method to the purpose of the evaluation, and the fairness of the evaluation pricing

Oct 16 00:00